4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-078815
Chief Financial Officer sold 28,088 shares at an average $96.29 ($2,704,624)
- Chief Financial Officer acquired 28,088 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2025-08-12 | Option exercise 10b5-1 | +24,611 | $6.88 | $169,324 | 141,526 | D: show line 1 in the form |
| Smith Hunter C Chief Financial Officer | 2025-08-12 | Sale 10b5-1 | −24,611 | $96.33 | $2,370,832 | 116,915 | D: show line 2 in the form |
| Smith Hunter C Chief Financial Officer | 2025-08-13 | Option exercise 10b5-1 | +3,477 | $6.88 | $23,922 | 120,392 | D: show line 3 in the form |
| Smith Hunter C Chief Financial Officer | 2025-08-13 | Sale 10b5-1 | −3,477 | $96.00 | $333,792 | 116,915 | D: show line 4 in the form |
| Open-market sales · 28,088 sh · avg $96.29 · $2,704,624 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2025-08-12 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −24,611 | 3,477 | D: show line 5 in the form | |||||
| Smith Hunter C Chief Financial Officer | 2025-08-13 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −3,477 | 0 | D: show line 6 in the form |
Loading xslF345X05/tm2523328-3_4seq1.xml…